首页 > 最新文献

Journal of Feline Medicine and Surgery最新文献

英文 中文
Use of a novel three-dimensional anatomical plating system for treatment of caudal mandibular fractures in cats: 13 cases (2019-2023). 使用新型三维解剖钢板系统治疗猫下颌骨尾端骨折:13 例病例(2019-2023 年)。
IF 1.9 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-05-01 DOI: 10.1177/1098612X241243134
Annabel McFadzean, Alix Freeman, James Sage, Andrew Perry

Case series summary: A total of 13 cases of cats with a caudal mandibular fracture treated with a novel surgical technique using the Ramus Anatomical Plate system were reviewed. Preoperative, immediate postoperative and a minimum of 8 weeks postoperative CT images were required as inclusion criteria. The outcome and complications were determined from clinical data and radiographic follow-up examinations. All cases achieved adequate anatomical reduction, resulting in a functional and atraumatic occlusion postoperatively. No intraoperative complications were reported. Time to voluntary food intake was in the range of 1-25 days. No evidence of disruptions to the implants or screw loosening was observed in the 8-week postoperative CT imaging, with radiographic evidence of complete osseous union in all fractures. The most common postoperative complication was swelling at the surgical site. Two cats had postoperative exophthalmos due to retrobulbar haemorrhage, and one cat exhibited partial wound dehiscence 5 days postoperatively, which resolved with medical management. Longer-term complications included intraoral plate exposure in one cat, which required plate removal 10 months postoperatively.

Relevance and novel information: In this case series, rigid internal fixation of caudal mandibular fractures using the Ramus Anatomical Plate osteosynthesis system was associated with a minimal complication rate, and satisfactory radiographic and clinical outcomes. The reported outcomes of this novel technique are favourable when compared with previous techniques described for the management of these fracture types.

病例系列摘要:本研究共回顾了 13 例猫咪下颌骨尾端骨折病例,这些病例均采用了使用 Ramus 解剖板系统的新型手术技术进行治疗。纳入标准包括术前、术后即刻和术后至少 8 周的 CT 图像。根据临床数据和影像学随访检查确定了结果和并发症。所有病例都实现了充分的解剖学缩小,术后实现了功能性无创咬合。无术中并发症报告。自愿进食时间为 1-25 天。在术后8周的CT成像中,没有观察到植入物破损或螺钉松动的迹象,所有骨折都有完全骨结合的影像学证据。最常见的术后并发症是手术部位肿胀。两只猫在术后因球后出血而出现眼球外翻,一只猫在术后 5 天出现部分伤口裂开,经药物治疗后愈合。长期并发症包括一只猫的口内钢板外露,需要在术后 10 个月取出钢板:在这组病例中,使用 Ramus 解剖钢板骨合成系统对下颌骨尾骨骨折进行刚性内固定,并发症发生率极低,且放射学和临床效果令人满意。与以往治疗此类骨折的技术相比,这种新型技术的疗效更佳。
{"title":"Use of a novel three-dimensional anatomical plating system for treatment of caudal mandibular fractures in cats: 13 cases (2019-2023).","authors":"Annabel McFadzean, Alix Freeman, James Sage, Andrew Perry","doi":"10.1177/1098612X241243134","DOIUrl":"10.1177/1098612X241243134","url":null,"abstract":"<p><strong>Case series summary: </strong>A total of 13 cases of cats with a caudal mandibular fracture treated with a novel surgical technique using the Ramus Anatomical Plate system were reviewed. Preoperative, immediate postoperative and a minimum of 8 weeks postoperative CT images were required as inclusion criteria. The outcome and complications were determined from clinical data and radiographic follow-up examinations. All cases achieved adequate anatomical reduction, resulting in a functional and atraumatic occlusion postoperatively. No intraoperative complications were reported. Time to voluntary food intake was in the range of 1-25 days. No evidence of disruptions to the implants or screw loosening was observed in the 8-week postoperative CT imaging, with radiographic evidence of complete osseous union in all fractures. The most common postoperative complication was swelling at the surgical site. Two cats had postoperative exophthalmos due to retrobulbar haemorrhage, and one cat exhibited partial wound dehiscence 5 days postoperatively, which resolved with medical management. Longer-term complications included intraoral plate exposure in one cat, which required plate removal 10 months postoperatively.</p><p><strong>Relevance and novel information: </strong>In this case series, rigid internal fixation of caudal mandibular fractures using the Ramus Anatomical Plate osteosynthesis system was associated with a minimal complication rate, and satisfactory radiographic and clinical outcomes. The reported outcomes of this novel technique are favourable when compared with previous techniques described for the management of these fracture types.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"26 5","pages":"1098612X241243134"},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the effect of gabapentin on blood pressure in cats with and without chronic kidney disease. 评估加巴喷丁对患有和未患有慢性肾病的猫咪血压的影响。
IF 1.9 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-05-01 DOI: 10.1177/1098612X241240326
Jessica M Quimby, Sarah E Jones, Ashlie Saffire, Katelyn K Brusach, Kim Kurdziel, Zach George, Rene E Paschall, Turi K Aarnes

Objectives: The aim of the present study was to assess the effect of gabapentin on blood pressure (BP) in cats with and without chronic kidney disease (CKD).

Methods: A randomized, blinded, placebo-controlled crossover study was performed. A total of 29 cats were included: 13 cats with stable CKD (IRIS stage 2-4) and 16 apparently healthy cats (serum creatinine <1.6 mg/dl and urine specific gravity >1.035). The cats were evaluated twice, approximately 1 week apart, and BP (Doppler sphygmomanometry) was obtained 3 h after cats received either a single dose of gabapentin 10mg/kg PO or placebo. For each cat, BP readings were obtained at each visit using the same Doppler and sphygmomanometer unit, and the same cat holder and Doppler operator, in the same location.

Results: After administration of a single dose of gabapentin (10 mg/kg PO), BP was significantly lower (median 122 mmHg, range 82-170) than after administration of the placebo (median 150 mmHg, range 102-191; P = 0.001). In the CKD subgroup, BP was significantly lower after administration of gabapentin (median 129 mmHg, range 96-170) than after administration of the placebo (median 155 mmHg, range 102-191; P = 0.008). In the healthy cat subgroup, BP was significantly lower after administration of gabapentin (median 121 mmHg, range 82-139) than after administration of the placebo (median 137 mmHg, range 102-177; P = 0.002). The median change in BP was -12 mmHg (range -95 to 10) for healthy cats and -12 mmHg (range -43 to 21) for cats with CKD (no significant difference between subgroups).

Conclusions and relevance: Gabapentin may decrease arterial BP in cats with and without CKD and these findings should be taken into account when gabapentin is administered to patients in which measurement of BP is needed.

研究目的本研究旨在评估加巴喷丁对患有和未患有慢性肾病(CKD)的猫咪血压(BP)的影响:方法:进行一项随机、盲法、安慰剂对照交叉研究。共纳入了 29 只猫:其中 13 只患有稳定的慢性肾脏病(IRIS 2-4 期),16 只明显健康(血清肌酐 1.035)。对这些猫进行了两次评估,每次间隔约一周,在猫接受单剂量加巴喷丁 10 毫克/千克(PO)或安慰剂治疗 3 小时后测量血压(多普勒血压计)。每只猫每次就诊时都在同一地点使用相同的多普勒和血压计装置、相同的猫架和多普勒操作员测量血压:服用单剂量加巴喷丁(10 毫克/千克 PO)后,血压(中位数 122 mmHg,范围 82-170)明显低于服用安慰剂后(中位数 150 mmHg,范围 102-191;P = 0.001)。在慢性肾脏病亚组中,服用加巴喷丁后的血压(中位数 129 mmHg,范围 96-170)明显低于服用安慰剂后的血压(中位数 155 mmHg,范围 102-191;P = 0.008)。在健康猫亚组中,服用加巴喷丁后的血压(中位数 121 mmHg,范围 82-139)明显低于服用安慰剂后的血压(中位数 137 mmHg,范围 102-177;P = 0.002)。健康猫的血压变化中位数为-12毫米汞柱(范围为-95至10),患有慢性肾脏病的猫的血压变化中位数为-12毫米汞柱(范围为-43至21)(亚组之间无显著差异):加巴喷丁可能会降低患有或未患有慢性肾脏病的猫的动脉血压,在对需要测量血压的患者施用加巴喷丁时应考虑到这些发现。
{"title":"Assessment of the effect of gabapentin on blood pressure in cats with and without chronic kidney disease.","authors":"Jessica M Quimby, Sarah E Jones, Ashlie Saffire, Katelyn K Brusach, Kim Kurdziel, Zach George, Rene E Paschall, Turi K Aarnes","doi":"10.1177/1098612X241240326","DOIUrl":"10.1177/1098612X241240326","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of the present study was to assess the effect of gabapentin on blood pressure (BP) in cats with and without chronic kidney disease (CKD).</p><p><strong>Methods: </strong>A randomized, blinded, placebo-controlled crossover study was performed. A total of 29 cats were included: 13 cats with stable CKD (IRIS stage 2-4) and 16 apparently healthy cats (serum creatinine <1.6 mg/dl and urine specific gravity >1.035). The cats were evaluated twice, approximately 1 week apart, and BP (Doppler sphygmomanometry) was obtained 3 h after cats received either a single dose of gabapentin 10mg/kg PO or placebo. For each cat, BP readings were obtained at each visit using the same Doppler and sphygmomanometer unit, and the same cat holder and Doppler operator, in the same location.</p><p><strong>Results: </strong>After administration of a single dose of gabapentin (10 mg/kg PO), BP was significantly lower (median 122 mmHg, range 82-170) than after administration of the placebo (median 150 mmHg, range 102-191; <i>P</i> = 0.001). In the CKD subgroup, BP was significantly lower after administration of gabapentin (median 129 mmHg, range 96-170) than after administration of the placebo (median 155 mmHg, range 102-191; <i>P</i> = 0.008). In the healthy cat subgroup, BP was significantly lower after administration of gabapentin (median 121 mmHg, range 82-139) than after administration of the placebo (median 137 mmHg, range 102-177; <i>P</i> = 0.002). The median change in BP was -12 mmHg (range -95 to 10) for healthy cats and -12 mmHg (range -43 to 21) for cats with CKD (no significant difference between subgroups).</p><p><strong>Conclusions and relevance: </strong>Gabapentin may decrease arterial BP in cats with and without CKD and these findings should be taken into account when gabapentin is administered to patients in which measurement of BP is needed.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"26 5","pages":"1098612X241240326"},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alpha-chloralose poisoning in 25 cats: clinical picture and evaluation of treatment with intravenous lipid emulsion 25 只猫的α-氯糖中毒:临床表现和静脉注射脂质乳剂治疗评估
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-04-30 DOI: 10.1177/1098612x241235776
Sandra Lundgren, Kristoffer Dreimanis, Karolina Engdahl, Ulrika Windahl, Cecilia Tegner
ObjectivesThe aims of this study were to describe the clinical picture and progression in cats with alpha-chloralose (AC) intoxication and to determine if treatment with intravenous (IV) lipid emulsion (ILE) influenced either the serum concentration of AC or the clinical signs.MethodsCats with suspected AC poisoning admitted to a university small animal hospital were included. The cats were randomised into two groups: one receiving 20% ILE at a dose of 300 mg/kg as a 2 min bolus, followed by a 1500 mg/kg continuous rate infusion over 30 mins (IL+ group) and the other receiving IV fluid therapy with Ringer’s acetate (IL− group). Serum samples were drawn at 0, 2, 12 and 24 h after admission. Samples were tested for AC with a novel validated, quantitative, ultra-high-performance liquid chromatography-tandem mass spectrometry method. Vital and predefined clinical signs were noted at the times of sampling and patients were scored using a previously described intoxication severity score. Telephone interviews were conducted after discharge to assess outcome.ResultsA total of 25 cats were enrolled: 13 cats in the IL+ group and 12 in the IL− group. The most common clinical signs at presentation were tremor (n = 22, 88.0%), cranial nerve deficits (n = 20, 80.0%) and bradycardia (n = 19, 76.0%). No significant difference in AC concentration or change in intoxication score over time was found between the IL+ and IL− groups at any time point ( P >0.05). All cats recovered within 72 h.Conclusions and relevanceILE did not have any effect on the AC serum concentration or clinical signs in AC-poisoned cats. All cats survived until follow-up. In cats with an acute onset of the described neurological signs, AC intoxication is an important differential diagnosis with an excellent prognosis.
本研究旨在描述α-氯醛糖(AC)中毒猫的临床表现和病情发展,并确定静脉注射(IV)脂质乳剂(ILE)是否会影响 AC 的血清浓度或临床症状。这些猫被随机分为两组:一组接受 20% ILE,剂量为 300 毫克/千克(2 分钟),然后在 30 分钟内以 1500 毫克/千克的速度持续输注(IL+ 组);另一组接受醋酸林格氏液静脉输液治疗(IL- 组)。在入院后的 0、2、12 和 24 小时抽取血清样本。采用一种新型的、经过验证的、定量的超高效液相色谱-串联质谱法对样本进行 AC 检测。采样时会记录生命体征和预定义的临床体征,并使用之前描述的中毒严重程度评分对患者进行评分。出院后进行电话访谈以评估疗效:IL+ 组 13 只,IL- 组 12 只。发病时最常见的临床症状是震颤(22 只,88.0%)、颅神经缺损(20 只,80.0%)和心动过缓(19 只,76.0%)。在任何时间点,IL+ 组和 IL- 组的 AC 浓度或中毒评分随时间的变化均无明显差异(P >0.05)。所有猫都在 72 小时内恢复了健康。结论和相关性 ILE 对 AC 中毒猫的 AC 血清浓度或临床症状没有任何影响。所有猫都存活到了后续治疗。对于急性出现所述神经症状的猫,AC 中毒是一个重要的鉴别诊断,预后极佳。
{"title":"Alpha-chloralose poisoning in 25 cats: clinical picture and evaluation of treatment with intravenous lipid emulsion","authors":"Sandra Lundgren, Kristoffer Dreimanis, Karolina Engdahl, Ulrika Windahl, Cecilia Tegner","doi":"10.1177/1098612x241235776","DOIUrl":"https://doi.org/10.1177/1098612x241235776","url":null,"abstract":"ObjectivesThe aims of this study were to describe the clinical picture and progression in cats with alpha-chloralose (AC) intoxication and to determine if treatment with intravenous (IV) lipid emulsion (ILE) influenced either the serum concentration of AC or the clinical signs.MethodsCats with suspected AC poisoning admitted to a university small animal hospital were included. The cats were randomised into two groups: one receiving 20% ILE at a dose of 300 mg/kg as a 2 min bolus, followed by a 1500 mg/kg continuous rate infusion over 30 mins (IL+ group) and the other receiving IV fluid therapy with Ringer’s acetate (IL− group). Serum samples were drawn at 0, 2, 12 and 24 h after admission. Samples were tested for AC with a novel validated, quantitative, ultra-high-performance liquid chromatography-tandem mass spectrometry method. Vital and predefined clinical signs were noted at the times of sampling and patients were scored using a previously described intoxication severity score. Telephone interviews were conducted after discharge to assess outcome.ResultsA total of 25 cats were enrolled: 13 cats in the IL+ group and 12 in the IL− group. The most common clinical signs at presentation were tremor (n = 22, 88.0%), cranial nerve deficits (n = 20, 80.0%) and bradycardia (n = 19, 76.0%). No significant difference in AC concentration or change in intoxication score over time was found between the IL+ and IL− groups at any time point ( P &gt;0.05). All cats recovered within 72 h.Conclusions and relevanceILE did not have any effect on the AC serum concentration or clinical signs in AC-poisoned cats. All cats survived until follow-up. In cats with an acute onset of the described neurological signs, AC intoxication is an important differential diagnosis with an excellent prognosis.","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"11 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140836158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determination of clopidogrel effect in cats using point-of-care Plateletworks ADP and shipped samples for PFA-200 analysis in a clinical practice setting 在临床实践中使用护理点血小板工作站 ADP 和运送的 PFA-200 分析样本确定氯吡格雷在猫体内的作用
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-04-29 DOI: 10.1177/1098612x241241404
Matthew R Kornya, Anthony CG Abrams-Ogg, Shauna L Blois, R Darren Wood
ObjectivesClopidogrel is the recommended first-line antithrombotic in cats for a variety of conditions; however, it is ineffective in 15–20% of cats. The determination of clopidogrel effectiveness with platelet function assays has historically been limited to specialty centers; however, recent work has suggested that in-hospital or shipped analyses of samples may be feasible. The aim of the present study was to investigate the utility of an in-house analysis and shipping of blood samples collected in primary practices for the determination of clopidogrel effectiveness.MethodsCitrated blood samples were collected from cats receiving clopidogrel therapy by veterinarians in clinical practices across Canada, a median of 304.4 km from the reference laboratory (range 8–4425). Samples were analyzed in-house using Plateletworks ADP and shipped for remote analysis using PFA-200 P2Y and COL/ADP cartridges.ResultsA total of 30 samples were collected from 25 cats. Of these, the percentage of samples analyzable for the presence or absence of the clopidogrel effect was 86% for Plateletworks ADP, 90% for PFA-200 P2Y and 87% for PFA-200 COL/ADP. There was no significant difference in the number of samples unable to be analyzed by each modality ( P = 0.689) due to flow obstruction or other sample characteristics. The prevalence of absence of clopidogrel effectiveness on platelet function assays was 8% with the PFA-200 COL/ADP assay, 25% with the PFA-200 P2Y assay and 30% with the Plateletworks ADP assay.Conclusions and relevanceThe results of this study confirm that samples of feline blood can be collected in clinical practices and shipped to a reference laboratory for PFA-200 analysis with a high rate of success, comparable to point-of-care analysis.
目标氯吡格雷是推荐的猫科动物一线抗血栓药物,可用于治疗多种疾病;但有 15-20% 的猫科动物服用氯吡格雷无效。用血小板功能测定法来确定氯吡格雷的疗效历来仅限于专科中心;不过,最近的研究表明,在医院内或运输途中对样本进行分析也是可行的。本研究的目的是调查内部分析和运输在基层诊所采集的血液样本对确定氯吡格雷有效性的实用性。方法加拿大各地临床诊所的兽医从接受氯吡格雷治疗的猫身上采集了硝酸血液样本,样本距离参考实验室的中位数为 304.4 公里(范围为 8-4425 公里)。使用 Plateletworks ADP 对样本进行内部分析,然后使用 PFA-200 P2Y 和 COL/ADP 血盒运送样本进行远程分析。其中,可分析是否存在氯吡格雷效应的样本百分比为:Plateletworks ADP 86%、PFA-200 P2Y 90%、PFA-200 COL/ADP 87%。由于血流阻塞或其他样本特征,每种模式无法分析的样本数量没有明显差异(P = 0.689)。PFA-200 COL/ADP 分析法血小板功能测定中氯吡格雷无效的发生率为 8%,PFA-200 P2Y 分析法为 25%,Plateletworks ADP 分析法为 30%。
{"title":"Determination of clopidogrel effect in cats using point-of-care Plateletworks ADP and shipped samples for PFA-200 analysis in a clinical practice setting","authors":"Matthew R Kornya, Anthony CG Abrams-Ogg, Shauna L Blois, R Darren Wood","doi":"10.1177/1098612x241241404","DOIUrl":"https://doi.org/10.1177/1098612x241241404","url":null,"abstract":"ObjectivesClopidogrel is the recommended first-line antithrombotic in cats for a variety of conditions; however, it is ineffective in 15–20% of cats. The determination of clopidogrel effectiveness with platelet function assays has historically been limited to specialty centers; however, recent work has suggested that in-hospital or shipped analyses of samples may be feasible. The aim of the present study was to investigate the utility of an in-house analysis and shipping of blood samples collected in primary practices for the determination of clopidogrel effectiveness.MethodsCitrated blood samples were collected from cats receiving clopidogrel therapy by veterinarians in clinical practices across Canada, a median of 304.4 km from the reference laboratory (range 8–4425). Samples were analyzed in-house using Plateletworks ADP and shipped for remote analysis using PFA-200 P2Y and COL/ADP cartridges.ResultsA total of 30 samples were collected from 25 cats. Of these, the percentage of samples analyzable for the presence or absence of the clopidogrel effect was 86% for Plateletworks ADP, 90% for PFA-200 P2Y and 87% for PFA-200 COL/ADP. There was no significant difference in the number of samples unable to be analyzed by each modality ( P = 0.689) due to flow obstruction or other sample characteristics. The prevalence of absence of clopidogrel effectiveness on platelet function assays was 8% with the PFA-200 COL/ADP assay, 25% with the PFA-200 P2Y assay and 30% with the Plateletworks ADP assay.Conclusions and relevanceThe results of this study confirm that samples of feline blood can be collected in clinical practices and shipped to a reference laboratory for PFA-200 analysis with a high rate of success, comparable to point-of-care analysis.","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"24 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140828766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review 患有和未患有慢性肾病的猫体内血液成纤维细胞生长因子 23 的浓度:范围综述
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-04-29 DOI: 10.1177/1098612x241234984
Stacie Summers, Helen T Michael, Donald Szlosek, Rebekah Mack
ObjectivesThis study undertook a scoping review of research on blood fibroblast growth factor 23 (FGF-23) concentrations in healthy non-azotemic cats and cats with chronic kidney disease (CKD) to describe the volume and nature of existing literature, to determine whether published studies provide adequate evidence to support the use of FGF-23 as a biomarker in clinical practice and to identify any existing gaps in knowledge.MethodsPRISMA Extension for Scoping Reviews guidelines were used to design and perform the scoping review. Online databases were used to identify observational and clinical studies of blood FGF-23 concentrations in healthy cats and cats with CKD published before December 2022. Study and population characteristics and descriptive data on FGF-23 concentrations were extracted.ResultsA total of 205 publications were reviewed; 17 were retained for inclusion. Most studies were retrospective. Most studies included cats with International Renal Interest Society stage 2–4 CKD, with some variation. Key concepts explored in the literature include FGF-23 concentrations by CKD stage, effect of dietary phosphate restriction on FGF-23 concentrations, relationship between FGF-23 concentrations and blood phosphorus, calcium and magnesium concentrations, and FGF-23 concentrations in cats with progressive CKD. FGF-23 concentrations tended to be higher in cats with CKD compared with healthy cats, with an overlap between healthy and CKD populations, and there was significant variation within stages of CKD.Conclusions and relevanceFGF-23 is a biomarker of interest for the management and monitoring of phosphate overload in cats. Studies support several potential clinical applications for measuring FGF-23 concentration in practice; however, evidence is limited. Research on FGF-23 in cats with CKD would benefit from longitudinal, prospective studies that standardize CKD diagnosis and categorize cats by stage using current guidelines. Studies should include cats with early-stage, non-azotemic CKD and use commercially available assays so such results are comparable across studies.
目标本研究对健康非氮质血症猫和慢性肾脏病(CKD)猫血液中成纤维细胞生长因子 23 (FGF-23) 浓度的研究进行了范围界定综述,以描述现有文献的数量和性质,确定已发表的研究是否提供了足够的证据来支持在临床实践中使用 FGF-23 作为生物标记物,并找出现有的知识空白。我们使用在线数据库确定了 2022 年 12 月之前发表的有关健康猫咪和患有慢性肾脏病的猫咪血液中 FGF-23 浓度的观察性和临床研究。结果 共审查了 205 篇出版物,其中 17 篇被保留纳入。大多数研究为回顾性研究。大多数研究纳入了患有国际肾脏兴趣协会 2-4 期 CKD 的猫,但也有一些差异。文献中探讨的关键概念包括:按 CKD 阶段划分的 FGF-23 浓度、饮食磷酸盐限制对 FGF-23 浓度的影响、FGF-23 浓度与血磷、血钙和血镁浓度之间的关系,以及进行性 CKD 猫的 FGF-23 浓度。与健康猫相比,慢性肾脏病猫的 FGF-23 浓度往往更高,健康猫和慢性肾脏病猫的 FGF-23 浓度存在重叠,而且慢性肾脏病各阶段的 FGF-23 浓度也存在显著差异。研究支持在实践中测量 FGF-23 浓度的几种潜在临床应用;但证据有限。对患有慢性肾脏病(CKD)的猫进行 FGF-23 的研究将受益于纵向、前瞻性的研究,这些研究将对慢性肾脏病(CKD)的诊断进行标准化,并根据现行指南对猫进行分期分类。研究应包括早期非氮质血症 CKD 猫,并使用市场上可买到的检测方法,这样研究结果才具有可比性。
{"title":"Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review","authors":"Stacie Summers, Helen T Michael, Donald Szlosek, Rebekah Mack","doi":"10.1177/1098612x241234984","DOIUrl":"https://doi.org/10.1177/1098612x241234984","url":null,"abstract":"ObjectivesThis study undertook a scoping review of research on blood fibroblast growth factor 23 (FGF-23) concentrations in healthy non-azotemic cats and cats with chronic kidney disease (CKD) to describe the volume and nature of existing literature, to determine whether published studies provide adequate evidence to support the use of FGF-23 as a biomarker in clinical practice and to identify any existing gaps in knowledge.MethodsPRISMA Extension for Scoping Reviews guidelines were used to design and perform the scoping review. Online databases were used to identify observational and clinical studies of blood FGF-23 concentrations in healthy cats and cats with CKD published before December 2022. Study and population characteristics and descriptive data on FGF-23 concentrations were extracted.ResultsA total of 205 publications were reviewed; 17 were retained for inclusion. Most studies were retrospective. Most studies included cats with International Renal Interest Society stage 2–4 CKD, with some variation. Key concepts explored in the literature include FGF-23 concentrations by CKD stage, effect of dietary phosphate restriction on FGF-23 concentrations, relationship between FGF-23 concentrations and blood phosphorus, calcium and magnesium concentrations, and FGF-23 concentrations in cats with progressive CKD. FGF-23 concentrations tended to be higher in cats with CKD compared with healthy cats, with an overlap between healthy and CKD populations, and there was significant variation within stages of CKD.Conclusions and relevanceFGF-23 is a biomarker of interest for the management and monitoring of phosphate overload in cats. Studies support several potential clinical applications for measuring FGF-23 concentration in practice; however, evidence is limited. Research on FGF-23 in cats with CKD would benefit from longitudinal, prospective studies that standardize CKD diagnosis and categorize cats by stage using current guidelines. Studies should include cats with early-stage, non-azotemic CKD and use commercially available assays so such results are comparable across studies.","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"36 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140828803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psyllium husk powder increases defecation frequency and faecal score, bulk and moisture in healthy cats 车前子壳粉可增加健康猫咪的排便次数、粪便分量、体积和水分
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-04-18 DOI: 10.1177/1098612x241234151
Emeline Keller, Jeremy Laxalde, Nelly Tranier, Pablo Belmar von Kretschmann, Ailsa Jackson, Ingrid van Hoek
ObjectivesConstipation is the infrequent or difficult emission of hard, dry faeces and is a common digestive condition in cats. Psyllium is a low-fermentable fibre, with soluble and insoluble components and water-holding properties. It forms a mucilaginous gel with water and is used for the symptomatic treatment of constipation in various species. This study evaluated the effect of dietary psyllium on faecal characteristics in cats.MethodsHealthy neutered adult cats (six female and three male, aged 3.3–4.4 years) were consecutively fed a dry extruded diet containing either 6% psyllium (test) or 6% cellulose (control) for 10 days each. During the last 3 days (the collection days) of both feeding periods, bowel movements and faecal scores were recorded, and faeces were collected to measure wet weight and moisture. The statistical analysis used linear mixed models with diet, day and their interaction as fixed effects and animal as a random term.ResultsThe test diet was associated with significantly more bowel movements per day over 3 days ( P = 0.0052) and on collection day 2 ( P = 0.0229) than the control diet. The mean faecal score was higher (softer faeces) over all three collection days ( P <0.0001) and on collection days 1, 2 and 3 ( P = 0.0011, P = 0.0349, P = 0.0003, respectively) for the test diet vs the control diet; the total faecal wet weight ( P = 0.0003) and faecal moisture (%) were also higher ( P = 0.0426) for the test diet. Faeces associated with the test diet often had a dry shell and soft interior, which increased the faecal score.Conclusions and relevancePsyllium promoted more bowel movements and higher faecal moisture and faecal score in healthy cats, consistent with a previous uncontrolled clinical trial in constipated cats. Together, the studies support the use of dietary psyllium for managing cats with constipation.
目的便秘是指猫不经常或很难排出干硬的粪便,是猫常见的消化系统疾病。车前子是一种低发酵纤维,具有可溶性和不可溶性成分以及保水特性。它能与水形成粘液凝胶,用于治疗各种动物的便秘症状。本研究评估了车前子对猫粪便特征的影响。方法连续给绝育成年猫(六雌三雄,年龄 3.3-4.4 岁)喂食含 6% 车前子(试验)或 6% 纤维素(对照)的干挤压饲料,每种饲料喂食 10 天。在两个喂食期的最后 3 天(收集日),记录排便情况和粪便评分,并收集粪便以测量湿重和水分。统计分析采用线性混合模型,将日粮、日期及其交互作用作为固定效应,动物作为随机项。结果试验日粮在 3 天内(P = 0.0052)和第 2 天(P = 0.0229)的排便次数明显多于对照日粮。试验日粮与对照日粮相比,在所有三个采集日(P <0.0001)和采集日 1、2、3(分别为 P = 0.0011、P = 0.0349、P = 0.0003)的平均粪便评分更高(粪便更软);试验日粮的粪便总湿重(P = 0.0003)和粪便水分(%)也更高(P = 0.0426)。结论和相关性车前子能促进健康猫排便,提高粪便水分和粪便评分,这与之前在便秘猫身上进行的一项非对照临床试验一致。总之,这些研究支持使用车前子膳食治疗猫咪便秘。
{"title":"Psyllium husk powder increases defecation frequency and faecal score, bulk and moisture in healthy cats","authors":"Emeline Keller, Jeremy Laxalde, Nelly Tranier, Pablo Belmar von Kretschmann, Ailsa Jackson, Ingrid van Hoek","doi":"10.1177/1098612x241234151","DOIUrl":"https://doi.org/10.1177/1098612x241234151","url":null,"abstract":"ObjectivesConstipation is the infrequent or difficult emission of hard, dry faeces and is a common digestive condition in cats. Psyllium is a low-fermentable fibre, with soluble and insoluble components and water-holding properties. It forms a mucilaginous gel with water and is used for the symptomatic treatment of constipation in various species. This study evaluated the effect of dietary psyllium on faecal characteristics in cats.MethodsHealthy neutered adult cats (six female and three male, aged 3.3–4.4 years) were consecutively fed a dry extruded diet containing either 6% psyllium (test) or 6% cellulose (control) for 10 days each. During the last 3 days (the collection days) of both feeding periods, bowel movements and faecal scores were recorded, and faeces were collected to measure wet weight and moisture. The statistical analysis used linear mixed models with diet, day and their interaction as fixed effects and animal as a random term.ResultsThe test diet was associated with significantly more bowel movements per day over 3 days ( P = 0.0052) and on collection day 2 ( P = 0.0229) than the control diet. The mean faecal score was higher (softer faeces) over all three collection days ( P &lt;0.0001) and on collection days 1, 2 and 3 ( P = 0.0011, P = 0.0349, P = 0.0003, respectively) for the test diet vs the control diet; the total faecal wet weight ( P = 0.0003) and faecal moisture (%) were also higher ( P = 0.0426) for the test diet. Faeces associated with the test diet often had a dry shell and soft interior, which increased the faecal score.Conclusions and relevancePsyllium promoted more bowel movements and higher faecal moisture and faecal score in healthy cats, consistent with a previous uncontrolled clinical trial in constipated cats. Together, the studies support the use of dietary psyllium for managing cats with constipation.","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"1 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140626508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats 2024 ISFM 和 AAFP 关于猫长期使用非甾体抗炎药的共识指南
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-04-08 DOI: 10.1177/1098612x241241951
Samantha Taylor, Margaret Gruen, Kate KuKanich, B Duncan X Lascelles, Beatriz P Monteiro, Llibertat Real Sampietro, Sheilah Robertson, Paulo V Steagall
Practical relevance:Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and are effective for the management of pain in cats. These Guidelines will support veterinarians in decision-making around prescribing NSAIDs in situations of chronic pain, to minimise adverse effects and optimise pain management. Information is provided on mechanism of action, indications for use, screening prior to prescription, use in the presence of comorbidities, monitoring of efficacy, and avoidance and management of adverse effects.Clinical challenges:The cat's unique metabolism should be considered when prescribing any medications, including NSAIDs. Chronic pain may be challenging to detect in this species and comorbidities, particularly chronic kidney disease, are common in senior cats. Management of chronic pain may be complicated by prescription of other drugs with the potential for interactions with NSAIDs.Evidence base:These Guidelines have been created by a panel of experts brought together by the International Society of Feline Medicine (ISFM) and American Association of Feline Practitioners (AAFP). Information is based on the available literature, expert opinion and the panel members' experience.
实用意义:非甾体抗炎药(NSAIDs)在治疗猫科动物疼痛方面应用广泛,效果显著。本指南将帮助兽医在慢性疼痛的情况下就非甾体抗炎药的处方做出决策,以尽量减少不良反应并优化疼痛治疗。本指南提供了有关作用机制、使用适应症、处方前筛查、合并症情况下的使用、疗效监测以及避免和处理不良反应等方面的信息。临床挑战:在处方任何药物(包括非甾体抗炎药)时,都应考虑到猫咪独特的新陈代谢。慢性疼痛可能很难在猫科动物中发现,而且合并症,尤其是慢性肾病,在高龄猫中很常见。证据基础:本指南由国际猫科动物医学协会(ISFM)和美国猫科动物医师协会(AAFP)联合组成的专家小组制定。信息基于现有文献、专家意见和专家组成员的经验。
{"title":"2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats","authors":"Samantha Taylor, Margaret Gruen, Kate KuKanich, B Duncan X Lascelles, Beatriz P Monteiro, Llibertat Real Sampietro, Sheilah Robertson, Paulo V Steagall","doi":"10.1177/1098612x241241951","DOIUrl":"https://doi.org/10.1177/1098612x241241951","url":null,"abstract":"Practical relevance:Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and are effective for the management of pain in cats. These Guidelines will support veterinarians in decision-making around prescribing NSAIDs in situations of chronic pain, to minimise adverse effects and optimise pain management. Information is provided on mechanism of action, indications for use, screening prior to prescription, use in the presence of comorbidities, monitoring of efficacy, and avoidance and management of adverse effects.Clinical challenges:The cat's unique metabolism should be considered when prescribing any medications, including NSAIDs. Chronic pain may be challenging to detect in this species and comorbidities, particularly chronic kidney disease, are common in senior cats. Management of chronic pain may be complicated by prescription of other drugs with the potential for interactions with NSAIDs.Evidence base:These Guidelines have been created by a panel of experts brought together by the International Society of Feline Medicine (ISFM) and American Association of Feline Practitioners (AAFP). Information is based on the available literature, expert opinion and the panel members' experience.","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"74 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140564649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thank you to our reviewers 感谢我们的评论员
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-03-15 DOI: 10.1177/1098612x241238120
{"title":"Thank you to our reviewers","authors":"","doi":"10.1177/1098612x241238120","DOIUrl":"https://doi.org/10.1177/1098612x241238120","url":null,"abstract":"","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"37 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140149098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bicavitary effusion in cats: retrospective analysis of signalment, clinical investigations, diagnosis and outcome. 猫双腔积液:信号、临床检查、诊断和结果的回顾性分析。
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-03-01 DOI: 10.1177/1098612X241227122
Joshua J Hardwick, Christopher S F K Ioannides-Hoey, Natalie Finch, Victoria Black

Objectives: The aim of this study was to describe the clinical and diagnostic findings and outcome of cats with bicavitary effusion presenting to a referral centre.

Methods: Medical records of cats presenting with bicavitary effusion were identified and their history, physical examination findings, clinicopathological data, diagnostic imaging findings, aetiology of bicavitary effusions (cardiac disease, neoplasia, infectious disease, sterile inflammatory disease, severe hypoalbuminaemia, trauma, coagulopathy or 'open' if no definitive diagnosis was reached) and outcome were recorded. Cox regression analysis was performed to identify independent predictors of death in cats with bicavitary effusion. Kaplan-Meier curves were generated for survival analysis.

Results: In total, 103 cats with bicavitary effusion were included. Neoplasia and cardiac disease were the most common aetiologies of bicavitary effusion, in 21 (20.4%) and 20 (19.4%) cats, respectively, followed by infectious disease (n = 11, 10.7%), trauma (n = 13, 12.6%), hypoalbuminaemia (n = 6, 5.8%), sterile inflammatory disease (n = 4, 3.9%) and coagulopathy (n = 1, 1.0%). The median survival time for all cats with bicavitary effusion was 3 days. Cats with a neoplastic aetiology had a 2.03 times greater risk of death compared with cats in which no diagnosis was achieved. Neoplasia (P = 0.030) and pedigree breed status (P = 0.016) were independent predictors of death in the multivariable Cox regression model.

Conclusions and relevance: This study highlights that bicavitary effusions in cats generally carry a guarded to poor prognosis, particularly if neoplasia is the underlying aetiology or if the cat is a pedigree breed. Cardiac disease appeared to be associated with a better prognosis, suggesting that assessment for congestive heart failure should be considered early when evaluating cats with bicavitary effusion. The prognosis for cats with feline infectious peritonitis is likely to be markedly improved by the advent of novel antiviral drugs, compared with the historical cohort of cats presented here.

研究目的本研究旨在描述在转诊中心就诊的双腔积液猫的临床和诊断结果及预后:方法:对患有双腔积液的猫的病历进行鉴定,并记录其病史、体格检查结果、临床病理数据、影像学诊断结果、双腔积液的病因(心脏疾病、肿瘤、感染性疾病、无菌性炎症、严重低白蛋白血症、外伤、凝血病或未明确诊断的 "开放性")和结果。进行了 Cox 回归分析,以确定双腔积液猫死亡的独立预测因素。生成卡普兰-梅耶曲线进行生存分析:结果:共纳入了 103 只患有双腔积液的猫。肿瘤和心脏病是双腔积液最常见的病因,分别占 21 只(20.4%)和 20 只(19.4%),其次是传染病(11 只,10.7%)、外伤(13 只,12.6%)、低白蛋白血症(6 只,5.8%)、无菌性炎症(4 只,3.9%)和凝血病(1 只,1.0%)。所有患有双腔积液的猫的中位生存时间为 3 天。与未确诊的猫相比,有肿瘤病因的猫死亡风险高出 2.03 倍。在多变量 Cox 回归模型中,肿瘤(P = 0.030)和纯种品种状态(P = 0.016)是死亡的独立预测因素:本研究强调,猫咪双腔积液的预后一般较差,尤其是当肿瘤是基本病因或猫咪是纯种时。心脏病似乎与较好的预后有关,这表明在对患有双腔积液的猫进行评估时,应及早考虑充血性心力衰竭的评估。新型抗病毒药物的出现可能会明显改善猫传染性腹膜炎患者的预后,这一点与本文介绍的历史上的猫群相比是一致的。
{"title":"Bicavitary effusion in cats: retrospective analysis of signalment, clinical investigations, diagnosis and outcome.","authors":"Joshua J Hardwick, Christopher S F K Ioannides-Hoey, Natalie Finch, Victoria Black","doi":"10.1177/1098612X241227122","DOIUrl":"10.1177/1098612X241227122","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to describe the clinical and diagnostic findings and outcome of cats with bicavitary effusion presenting to a referral centre.</p><p><strong>Methods: </strong>Medical records of cats presenting with bicavitary effusion were identified and their history, physical examination findings, clinicopathological data, diagnostic imaging findings, aetiology of bicavitary effusions (cardiac disease, neoplasia, infectious disease, sterile inflammatory disease, severe hypoalbuminaemia, trauma, coagulopathy or 'open' if no definitive diagnosis was reached) and outcome were recorded. Cox regression analysis was performed to identify independent predictors of death in cats with bicavitary effusion. Kaplan-Meier curves were generated for survival analysis.</p><p><strong>Results: </strong>In total, 103 cats with bicavitary effusion were included. Neoplasia and cardiac disease were the most common aetiologies of bicavitary effusion, in 21 (20.4%) and 20 (19.4%) cats, respectively, followed by infectious disease (n = 11, 10.7%), trauma (n = 13, 12.6%), hypoalbuminaemia (n = 6, 5.8%), sterile inflammatory disease (n = 4, 3.9%) and coagulopathy (n = 1, 1.0%). The median survival time for all cats with bicavitary effusion was 3 days. Cats with a neoplastic aetiology had a 2.03 times greater risk of death compared with cats in which no diagnosis was achieved. Neoplasia (<i>P</i> = 0.030) and pedigree breed status (<i>P</i> = 0.016) were independent predictors of death in the multivariable Cox regression model.</p><p><strong>Conclusions and relevance: </strong>This study highlights that bicavitary effusions in cats generally carry a guarded to poor prognosis, particularly if neoplasia is the underlying aetiology or if the cat is a pedigree breed. Cardiac disease appeared to be associated with a better prognosis, suggesting that assessment for congestive heart failure should be considered early when evaluating cats with bicavitary effusion. The prognosis for cats with feline infectious peritonitis is likely to be markedly improved by the advent of novel antiviral drugs, compared with the historical cohort of cats presented here.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"26 3","pages":"1098612X241227122"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140175028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of analgesic efficacy of tramadol, morphine and methadone in cats undergoing ovariohysterectomy. 比较曲马多、吗啡和美沙酮对接受卵巢切除术的猫的镇痛效果。
IF 1.7 2区 农林科学 Q2 VETERINARY SCIENCES Pub Date : 2024-03-01 DOI: 10.1177/1098612X231224662
Mariela Goich, Alejandra Bascuñán, Patricio Faúndez, Daniela Siel

Objectives: The aim of this study was to compare the analgesic efficacy and the effect on physiological variables and behavior of the use of tramadol, methadone and morphine as preoperative analgesia in healthy cats undergoing elective ovariohysterectomy.

Methods: Cats undergoing ovariohysterectomy were randomly assigned to receive one of the following premedication treatments intramuscularly: methadone (0.2 mg/kg; n = 10); morphine (0.2 mg/kg; n = 10); or tramadol (3 mg/kg; n = 10). Induction of anesthesia was done with propofol, and maintenance of anesthesia was done with isoflurane. Intraoperative heart rate, arterial blood pressure, respiratory rate, end-tidal isoflurane concentration and frequency of rescue analgesia (fentanyl 2.5 µg/kg) were compared between groups. Postoperative analgesia was assessed using the UNESP-Botucatu Multidimensional Composite Pain Scale, and perioperative serum glucose, cortisol concentrations and postoperative rescue analgesia were evaluated.

Results: Intraoperative rescue analgesia was required in 76.5% of cats at some time during surgery, and 27% of cats required postoperative rescue analgesia up to 6 h after extubation. There were no significant differences between groups with respect to intraoperative and postoperative rescue analgesia, pain scale scores and end-tidal isoflurane concentrations. In the immediate postoperative period, after extubation, most of the patients presented with hypothermia; however, 1-6 h postoperatively, hyperthermia was observed in most of the patients, and was most common in the tramadol group.

Conclusions and clinical relevance: Under the conditions of this study, methadone, morphine and tramadol produced satisfactory postoperative analgesia in most of the cats undergoing ovariohysterectomy, and the effects lasted up to 6 h postoperatively. Intraoperative analgesia was not sufficient in most cases. Significant cardiovascular or respiratory effects contraindicating the use of these drugs were not found. Postanesthetic hyperthermia occurred with all opioids studied and was more frequent in the tramadol group.

研究目的本研究旨在比较曲马多、美沙酮和吗啡作为术前镇痛剂对接受择期卵巢切除术的健康猫咪的镇痛效果以及对生理变量和行为的影响:方法:接受卵巢切除术的猫被随机分配到肌肉注射以下其中一种术前用药:美沙酮(0.2 毫克/千克;n = 10);吗啡(0.2 毫克/千克;n = 10);或曲马多(3 毫克/千克;n = 10)。麻醉诱导采用异丙酚,麻醉维持采用异氟醚。对各组的术中心率、动脉血压、呼吸频率、潮气末异氟醚浓度和镇痛抢救频率(芬太尼 2.5 µg/kg)进行了比较。术后镇痛采用 UNESP-Botucatu 多维综合疼痛量表进行评估,并对围术期血清葡萄糖、皮质醇浓度和术后抢救性镇痛进行评估:结果:76.5%的猫在手术过程中需要术中镇痛,27%的猫在拔管后6小时内需要术后镇痛。在术中和术后抢救镇痛、疼痛量表评分和潮气末异氟醚浓度方面,各组之间没有明显差异。在拔管后的术后初期,大多数患者出现低体温;但在术后1-6小时,大多数患者出现高热,曲马多组最为常见:在本研究的条件下,美沙酮、吗啡和曲马多对大多数接受卵巢切除术的猫产生了令人满意的术后镇痛效果,且效果可持续到术后6小时。大多数病例的术中镇痛效果并不充分。没有发现使用这些药物会对心血管或呼吸系统造成严重影响。所研究的所有阿片类药物都会出现麻醉后高热,而曲马多组更常见。
{"title":"Comparison of analgesic efficacy of tramadol, morphine and methadone in cats undergoing ovariohysterectomy.","authors":"Mariela Goich, Alejandra Bascuñán, Patricio Faúndez, Daniela Siel","doi":"10.1177/1098612X231224662","DOIUrl":"10.1177/1098612X231224662","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to compare the analgesic efficacy and the effect on physiological variables and behavior of the use of tramadol, methadone and morphine as preoperative analgesia in healthy cats undergoing elective ovariohysterectomy.</p><p><strong>Methods: </strong>Cats undergoing ovariohysterectomy were randomly assigned to receive one of the following premedication treatments intramuscularly: methadone (0.2 mg/kg; n = 10); morphine (0.2 mg/kg; n = 10); or tramadol (3 mg/kg; n = 10). Induction of anesthesia was done with propofol, and maintenance of anesthesia was done with isoflurane. Intraoperative heart rate, arterial blood pressure, respiratory rate, end-tidal isoflurane concentration and frequency of rescue analgesia (fentanyl 2.5 µg/kg) were compared between groups. Postoperative analgesia was assessed using the UNESP-Botucatu Multidimensional Composite Pain Scale, and perioperative serum glucose, cortisol concentrations and postoperative rescue analgesia were evaluated.</p><p><strong>Results: </strong>Intraoperative rescue analgesia was required in 76.5% of cats at some time during surgery, and 27% of cats required postoperative rescue analgesia up to 6 h after extubation. There were no significant differences between groups with respect to intraoperative and postoperative rescue analgesia, pain scale scores and end-tidal isoflurane concentrations. In the immediate postoperative period, after extubation, most of the patients presented with hypothermia; however, 1-6 h postoperatively, hyperthermia was observed in most of the patients, and was most common in the tramadol group.</p><p><strong>Conclusions and clinical relevance: </strong>Under the conditions of this study, methadone, morphine and tramadol produced satisfactory postoperative analgesia in most of the cats undergoing ovariohysterectomy, and the effects lasted up to 6 h postoperatively. Intraoperative analgesia was not sufficient in most cases. Significant cardiovascular or respiratory effects contraindicating the use of these drugs were not found. Postanesthetic hyperthermia occurred with all opioids studied and was more frequent in the tramadol group.</p>","PeriodicalId":15851,"journal":{"name":"Journal of Feline Medicine and Surgery","volume":"26 3","pages":"1098612X231224662"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140305849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Feline Medicine and Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1